Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Rupert Vessey. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Rupert Vessey zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:TECH / Bio-Techne Corporation | Director | 10 987 |
| US:BMY / Bristol-Myers Squibb Company | EVP & President, Research | 47 751 |
| US:CELG / Celgene Corp. | PRES., RESEARCH AND EARLY DEV. | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Rupert Vessey. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Rupert Vessey ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-03 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 1 640 | 10 987 | 17,55 | ||||
| 2024-10-28 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 1 462 | 9 347 | 18,54 | ||||
| 2023-10-30 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 1 625 | 7 885 | 25,96 | ||||
| 2023-05-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -50 385 | 47 751 | -51,34 | 67,06 | -3 378 818 | 3 202 182 | |
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -25 565 | 98 136 | -20,67 | 65,71 | -1 679 876 | 6 448 517 | |
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 5 438 | 123 701 | 4,60 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 44 541 | 118 263 | 60,42 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -3 774 | 73 722 | -4,87 | 65,71 | -247 990 | 4 844 273 | |
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 231 | 77 496 | 0,30 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 147 | 77 265 | 10,19 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 659 | 70 118 | -6,23 | 65,71 | -306 143 | 4 607 454 | |
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 1 284 | 74 777 | 1,75 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 824 | 73 493 | 11,91 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 500 | 65 669 | -6,41 | 65,71 | -295 695 | 4 315 110 | |
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 1 373 | 70 169 | 2,00 | ||||
| 2023-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 423 | 68 796 | 12,09 | ||||
| 2022-12-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 498 | 61 373 | -6,83 | 81,13 | -364 923 | 4 979 191 | |
| 2022-12-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 792 | 65 871 | 15,40 | ||||
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -45 910 | 57 079 | -44,58 | 78,88 | -3 621 381 | 4 502 392 | |
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 491 | 102 989 | 8,99 | 38,41 | 326 139 | 3 955 807 | |
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 491 | 94 498 | 9,87 | 47,81 | 405 955 | 4 517 949 | |
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 491 | 86 007 | 10,95 | 44,70 | 379 548 | 3 844 513 | |
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 21 288 | 77 516 | 37,86 | 72,42 | 1 541 677 | 5 613 709 | |
| 2022-11-09 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 5 843 | 56 228 | 11,60 | 70,89 | 414 210 | 3 986 003 | |
| 2022-10-31 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 338 | 1 565 | 27,55 | ||||
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 490 | 8 491 | -50,00 | ||||
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -5 294 | 0 | -100,00 | ||||
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -12 233 | 0 | -100,00 | ||||
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -21 288 | 0 | -100,00 | ||||
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -43 228 | 50 385 | -46,18 | 69,23 | -2 992 674 | 3 488 154 | |
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 490 | 93 613 | 9,97 | 38,41 | 326 101 | 3 595 675 | |
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 12 233 | 85 123 | 16,78 | 54,29 | 664 130 | 4 621 328 | |
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 5 294 | 72 890 | 7,83 | 55,52 | 293 923 | 4 046 853 | |
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 21 288 | 67 596 | 45,97 | 66,35 | 1 412 459 | 4 484 995 | |
| 2022-03-18 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -31 331 | 46 308 | -40,35 | 69,27 | -2 170 298 | 3 207 755 | |
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Performance Shares |
A - Award | 42 884 | 42 884 | |||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
A - Award | 28 589 | 28 589 | |||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
M - Exercise | -7 824 | 23 475 | -25,00 | ||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
M - Exercise | -7 423 | 14 848 | -33,33 | ||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 452 | 77 639 | -5,42 | 68,42 | -304 606 | 5 312 060 | |
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 878 | 82 091 | 1,08 | ||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 824 | 81 213 | 10,66 | ||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 299 | 73 389 | -5,53 | 68,42 | -294 138 | 5 021 275 | |
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 981 | 77 688 | 1,28 | ||||
| 2022-03-14 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 423 | 76 707 | 10,71 | ||||
| 2022-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -23 350 | 0 | -100,00 | ||||
| 2022-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -10 303 | 69 284 | -12,95 | 68,63 | -707 095 | 4 754 961 | |
| 2022-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 23 350 | 79 587 | 41,52 | ||||
| 2022-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -3 593 | 0 | -100,00 | ||||
| 2022-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -1 312 | 56 237 | -2,28 | 64,99 | -85 267 | 3 654 843 | |
| 2022-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 3 593 | 57 549 | 6,66 | ||||
| 2022-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -45 029 | 0 | -100,00 | ||||
| 2022-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -23 033 | 53 956 | -29,92 | 62,35 | -1 436 108 | 3 364 157 | |
| 2022-01-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 45 029 | 76 989 | 140,89 | ||||
| 2021-12-17 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -13 100 | 31 960 | -29,07 | 61,99 | -812 069 | 1 981 200 | |
| 2021-12-17 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -6 198 | 45 060 | -12,09 | 61,98 | -384 183 | 2 793 044 | |
| 2021-12-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -8 792 | 17 584 | -33,33 | ||||
| 2021-12-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 498 | 51 258 | -8,07 | 55,41 | -249 234 | 2 840 206 | |
| 2021-12-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 792 | 55 756 | 18,72 | ||||
| 2021-11-01 |
|
4 | TECH |
BIO-TECHNE Corp
Stock Option (right to buy) |
A - Award | 633 | 633 | |||||
| 2021-11-01 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 194 | 1 227 | 18,78 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 8 491 | -49,99 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 8 491 | -49,99 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -15 879 | 3 494 | -81,96 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -22 483 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -24 134 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -17 630 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -2 905 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -5 843 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -5 843 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -29 489 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -373 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -1 454 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -1 651 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -6 305 | 0 | -100,00 | ||||
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -140 653 | 46 964 | -74,97 | 68,08 | -9 575 656 | 3 197 309 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 187 617 | 4,74 | 47,81 | 405 859 | 8 969 969 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 179 128 | 4,97 | 44,70 | 379 458 | 8 007 022 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 15 879 | 170 639 | 10,26 | 55,52 | 881 602 | 9 473 877 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 22 483 | 154 760 | 17,00 | 60,53 | 1 360 896 | 9 367 623 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 24 134 | 132 277 | 22,32 | 61,34 | 1 480 380 | 8 113 871 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 17 630 | 108 143 | 19,48 | 56,44 | 995 037 | 6 103 591 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 2 905 | 90 513 | 3,32 | 54,20 | 157 451 | 4 905 805 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 5 843 | 87 608 | 7,15 | 61,01 | 356 481 | 5 344 964 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 29 489 | 81 765 | 56,41 | 63,41 | 1 869 897 | 5 184 719 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 373 | 52 276 | 0,72 | 56,44 | 21 052 | 2 950 457 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 1 454 | 51 903 | 2,88 | 54,20 | 78 807 | 2 813 143 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 1 651 | 50 449 | 3,38 | 60,53 | 99 935 | 3 053 678 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 6 305 | 48 798 | 14,84 | 63,41 | 399 800 | 3 094 281 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 5 843 | 42 493 | 15,94 | 58,78 | 343 452 | 2 497 739 | |
| 2021-08-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -17 740 | 36 650 | -32,62 | 68,01 | -1 206 497 | 2 492 566 | |
| 2021-05-11 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -17 245 | 0 | -100,00 | ||||
| 2021-05-11 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -7 994 | 54 390 | -12,81 | 64,44 | -515 133 | 3 504 892 | |
| 2021-05-11 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 17 245 | 62 384 | 38,20 | ||||
| 2021-05-07 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -30 546 | 45 139 | -40,36 | 64,29 | -1 963 802 | 2 901 986 | |
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Performance Shares |
A - Award | 46 949 | 46 949 | |||||
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
A - Award | 31 299 | 31 299 | |||||
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
M - Exercise | -7 423 | 22 271 | -25,00 | ||||
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -3 505 | 75 685 | -4,43 | 60,93 | -213 560 | 4 611 487 | |
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
J - Other | 139 | 79 190 | 0,18 | ||||
| 2021-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 7 423 | 79 051 | 10,36 | ||||
| 2021-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | 23 349 | 23 350 | 2 334 900,00 | ||||
| 2021-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -8 944 | 71 628 | -11,10 | 61,63 | -551 219 | 4 414 434 | |
| 2021-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 23 349 | 80 572 | 40,80 | ||||
| 2021-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -3 592 | 3 593 | -49,99 | ||||
| 2021-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -1 186 | 57 223 | -2,03 | 61,56 | -73 010 | 3 522 648 | |
| 2021-02-08 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 3 592 | 58 409 | 6,55 | ||||
| 2021-01-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -25 866 | 0 | -100,00 | ||||
| 2021-01-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -13 257 | 54 817 | -19,47 | 62,03 | -822 332 | 3 400 299 | |
| 2021-01-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 25 866 | 68 074 | 61,28 | ||||
| 2020-12-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -8 792 | 26 376 | -25,00 | ||||
| 2020-12-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -4 506 | 42 208 | -9,65 | 62,18 | -280 183 | 2 624 493 | |
| 2020-12-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 792 | 46 714 | 23,18 | ||||
| 2020-11-25 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -13 421 | 37 922 | -26,14 | 61,34 | -823 244 | 2 326 135 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 487 | 16 981 | -33,32 | ||||
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 16 980 | -33,33 | ||||
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 16 980 | -33,33 | ||||
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -12 233 | 12 233 | -50,00 | ||||
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -14 515 | 0 | -100,00 | ||||
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -47 012 | 51 343 | -47,80 | 61,31 | -2 882 306 | 3 147 839 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 487 | 98 355 | 9,44 | 38,41 | 325 986 | 3 777 816 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 89 868 | 10,43 | 47,81 | 405 859 | 4 296 589 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 81 379 | 11,65 | 44,70 | 379 458 | 3 637 641 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 12 233 | 72 890 | 20,17 | 54,29 | 664 130 | 3 957 198 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 14 515 | 60 657 | 31,46 | 54,94 | 797 454 | 3 332 496 | |
| 2020-11-23 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -10 579 | 46 142 | -18,65 | 61,25 | -647 964 | 2 826 198 | |
| 2020-11-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | -5 804 | 0 | -100,00 | ||||
| 2020-11-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -2 859 | 56 721 | -4,80 | 58,45 | -167 109 | 3 315 342 | |
| 2020-11-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 5 804 | 59 580 | 10,79 | ||||
| 2020-11-02 |
|
4 | TECH |
BIO-TECHNE Corp
Stock Option (Right to Buy) |
A - Award | 1 507 | 1 507 | |||||
| 2020-11-02 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 391 | 1 033 | 60,90 | ||||
| 2020-05-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | 10 707 | 0 | -100,00 | ||||
| 2020-05-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -5 274 | 53 776 | -8,93 | 60,26 | -317 811 | 3 240 542 | |
| 2020-05-05 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 10 707 | 59 050 | 22,15 | ||||
| 2020-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Performance Shares |
A - Award | 44 541 | 44 541 | |||||
| 2020-03-12 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Market Share Units |
A - Award | 29 694 | 29 694 | |||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 25 468 | -25,00 | ||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 25 468 | -25,00 | ||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -8 489 | 25 469 | -25,00 | ||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -24 466 | 24 466 | -50,00 | ||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
M - Exercise | -43 535 | 14 515 | -75,00 | ||||
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
S - Sale | -84 308 | 48 343 | -63,56 | 60,59 | -5 108 222 | 2 929 102 | |
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 132 651 | 6,84 | 38,41 | 326 062 | 5 095 125 | |
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 124 162 | 7,34 | 47,81 | 405 859 | 5 936 185 | |
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 8 489 | 115 673 | 7,92 | 44,70 | 379 458 | 5 170 583 | |
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 24 466 | 107 184 | 29,58 | 54,29 | 1 328 259 | 5 819 019 | |
| 2020-03-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 43 535 | 82 718 | 111,11 | 54,94 | 2 391 813 | 4 544 527 | |
| 2020-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | 23 349 | 46 699 | 100,00 | ||||
| 2020-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -8 923 | 39 183 | -18,55 | 59,06 | -526 992 | 2 314 148 | |
| 2020-03-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 23 349 | 48 106 | 94,31 | ||||
| 2020-02-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | 3 592 | 7 185 | 99,97 | ||||
| 2020-02-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -1 163 | 24 757 | -4,49 | 64,29 | -74 769 | 1 591 628 | |
| 2020-02-06 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 3 592 | 25 920 | 16,09 | ||||
| 2020-01-15 |
|
4/A | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -7 910 | 22 328 | -26,16 | 64,19 | -507 743 | 1 433 234 | |
| 2020-01-15 |
|
4/A | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 16 060 | 30 238 | 113,27 | ||||
| 2020-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
M - Exercise | 16 060 | 0 | -100,00 | ||||
| 2020-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
F - Taxes | -7 910 | 22 868 | -25,70 | 64,19 | -507 743 | 1 467 897 | |
| 2020-01-03 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
M - Exercise | 16 060 | 30 778 | 109,12 | ||||
| 2020-01-03 |
|
4/A | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 45 029 | 45 029 | |||||
| 2020-01-03 |
|
4/A | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 25 866 | 25 866 | |||||
| 2020-01-03 |
|
4/A | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 16 060 | 16 060 | |||||
| 2019-12-04 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 35 168 | 35 168 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 45 028 | 45 028 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 70 048 | 70 048 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 10 777 | 10 777 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 17 245 | 17 245 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 25 865 | 25 865 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 5 804 | 5 804 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 10 707 | 10 707 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Restricted Stock Units |
A - Award | 16 059 | 16 059 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 33 957 | 33 957 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 33 958 | 33 958 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 33 958 | 33 958 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 21 173 | 21 173 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 48 932 | 48 932 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 21 288 | 21 288 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 21 288 | 21 288 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 24 134 | 24 134 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 24 134 | 24 134 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 58 050 | 58 050 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 18 003 | 18 003 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 4 359 | 4 359 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 5 843 | 5 843 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 5 843 | 5 843 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 5 843 | 5 843 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Option (right to buy) |
A - Award | 35 794 | 35 794 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
A - Award | 613 | 613 | |||||
| 2019-11-27 |
|
4 | BMY |
BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value |
A - Award | 14 178 | 14 178 | |||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -37 660 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -5 794 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -9 271 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -3 120 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -5 756 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -18 257 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -18 257 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -18 257 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11 384 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11 384 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -26 308 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11 384 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -12 906 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -12 906 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -31 210 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -9 680 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -2 344 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -3 125 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -3 125 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -3 125 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -19 142 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -613 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -60 927 | 0 | -100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 24 209 | 60 927 | 65,93 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 13 906 | 36 718 | 60,96 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 8 634 | 22 812 | 60,90 | ||||
| 2019-11-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -5 369 | 0 | -100,00 | ||||
| 2019-11-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 644 | 14 178 | -15,72 | 108,03 | -285 631 | 1 531 649 | |
| 2019-11-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 369 | 16 822 | 46,88 | ||||
| 2019-10-28 |
|
4 | TECH |
BIO-TECHNE Corp
Stock Option (right to buy) |
A - Award | 2 011 | 2 011 | |||||
| 2019-10-28 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 495 | 642 | 336,73 | ||||
| 2019-07-02 |
|
4 | TECH |
BIO-TECHNE Corp
Stock Options (Right to buy) |
A - Award | 588 | 588 | |||||
| 2019-07-02 |
|
4 | TECH |
BIO-TECHNE Corp
Common Stock |
A - Award | 147 | 147 | |||||
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -6 731 | 0 | -100,00 | ||||
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 531 | 11 453 | -18,10 | 95,21 | -240 977 | 1 090 440 | |
| 2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 731 | 13 984 | 92,80 | ||||
| 2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 37 660 | 37 660 | |||||
| 2019-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 794 | 5 794 | |||||
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -5 350 | 0 | -100,00 | ||||
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 634 | 7 253 | -26,64 | 68,20 | -179 639 | 494 655 | |
| 2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 350 | 9 887 | 117,92 | ||||
| 2018-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 18 257 | 18 257 | |||||
| 2018-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 18 257 | 18 257 | |||||
| 2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 9 271 | 9 271 | |||||
| 2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (Right to Buy) |
A - Award | 18 257 | 18 257 | |||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
M - Exercise | -2 344 | 0 | -100,00 | ||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -781 | 0 | -100,00 | ||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -1 154 | 4 537 | -20,28 | 86,89 | -100 271 | 394 220 | |
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 344 | 5 691 | 70,03 | ||||
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -384 | 3 347 | -10,29 | 86,89 | -33 366 | 290 821 | |
| 2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 781 | 3 731 | 26,47 | ||||
| 2018-02-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -5 623 | 0 | -100,00 | ||||
| 2018-02-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -2 673 | 2 950 | -47,54 | 99,80 | -266 765 | 294 410 | |
| 2018-02-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 623 | 5 623 | |||||
| 2018-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 384 | 11 384 | |||||
| 2017-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 120 | 3 120 | |||||
| 2017-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 26 308 | 26 308 | |||||
| 2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 384 | 11 384 | |||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -781 | 1 562 | -33,33 | ||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -3 226 | 9 479 | -25,39 | ||||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -778 | 0 | -100,00 | 120,15 | -93 477 | ||
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -4 007 | 778 | -83,74 | 120,18 | -481 561 | 93 500 | |
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 781 | 4 785 | 19,51 | 100,80 | 78 725 | 482 328 | |
| 2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 226 | 4 004 | 414,65 | 104,97 | 338 633 | 420 300 | |
| 2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 756 | 5 756 | |||||
| 2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 384 | 11 384 | |||||
| 2017-03-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -4 000 | 778 | -83,72 | 124,42 | -497 672 | 96 797 | |
| 2017-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -5 623 | 5 623 | -50,00 | ||||
| 2017-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | -1 995 | 4 778 | -29,46 | 115,54 | -230 502 | 552 050 | |
| 2017-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 623 | 6 773 | 488,96 | ||||
| 2017-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 12 906 | 12 906 | |||||
| 2016-11-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -2 500 | 1 150 | -68,49 | 123,18 | -307 950 | 141 657 | |
| 2016-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 369 | 5 369 | |||||
| 2016-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 31 210 | 31 210 | |||||
| 2016-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 12 906 | 12 906 | |||||
| 2016-06-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
7 435 | ||||||||
| 2016-06-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
3 920 | ||||||||
| 2016-06-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
7 435 | ||||||||
| 2016-06-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
3 920 |